Stay updated on Dociparstat for Severe COVID-19 High-Risk Adults Clinical Trial
Sign up to get notified when there's something new on the Dociparstat for Severe COVID-19 High-Risk Adults Clinical Trial page.

Latest updates to the Dociparstat for Severe COVID-19 High-Risk Adults Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision updated to v3.4.2, and administrative notices about government funding lapse and NIH operating status were removed.SummaryDifference0.4%

- Check21 days agoChange DetectedA general site notice about government funding lapse and NIH operations was added, and the page revision updated to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedAdded Show glossary and new QC-related labels (Last Update Submitted that Met QC Criteria, No FEAR Act Data) along with Revision: v3.4.0. Removed the older capitalization variant labels (Last Update Submitted that met QC Criteria, No FEAR Act data) and the previous Revision: v3.3.4.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. No substantive content changes were observed.SummaryDifference0.0%

- Check64 days agoChange DetectedAdded a unified Locations section listing all study sites by state (Alabama, Florida, Georgia, Louisiana, Michigan, North Carolina, Texas, Wisconsin), replacing the prior per-state location headings. This clarifies where the trial is conducted and helps users find recruitment sites.SummaryDifference0.9%

- Check85 days agoChange DetectedMinor metadata update: Revision v3.3.2 added and v3.3.1 removed, with no changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Dociparstat for Severe COVID-19 High-Risk Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dociparstat for Severe COVID-19 High-Risk Adults Clinical Trial page.